Scholl Athlete's Foot 1% powder

Riik: Suurbritannia

keel: inglise

Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Toimeaine:

Tolnaftate

Saadav alates:

SSL International Plc

ATC kood:

D01AE18

INN (Rahvusvaheline Nimetus):

Tolnaftate

Annus:

10mg/1gram

Ravimvorm:

Cutaneous powder

Manustamisviis:

Cutaneous

Klass:

No Controlled Drug Status

Retsepti tüüp:

Valid as a prescribable product

Toote kokkuvõte:

BNF: 13100200; GTIN: 5000288454118

Toote omadused

OBJECT 1
SCHOLL ATHLETE'S FOOT POWDER
Summary of Product Characteristics Updated 05-Oct-2016 | SSL
International plc
1. Name of the medicinal product
Scholl Athletes Foot Powder
Superdrug Athletes Foot Powder
2. Qualitative and quantitative composition
Tolnaftate 1.0%w/w
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Powder for topical application
4. Clinical particulars
4.1 Therapeutic indications
For the prevention and treatment of Athlete's Foot.
4.2 Posology and method of administration
Wash and dry infected area, and apply twice daily or as directed by
your doctor. Dust feet liberally,
especially between toes. For added protection dust on socks, hosiery
and inside shoes. Continue treatment
for two weeks after symptoms disappear.
4.3 Contraindications
Not recommended for nail or scalp infections.
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
4.4 Special warnings and precautions for use
For external use only
Keep out of eyes
If symptoms do not improve within 10 days, discontinue use and consult
your doctor
Keep out of the reach and sight of children
4.5 Interaction with other medicinal products and other forms of
interaction
Not relevant to topical use
4.6 Pregnancy and lactation
No known restrictions.
4.7 Effects on ability to drive and use machines
None stated.
4.8 Undesirable effects
Adverse reactions have been ranked under headings of frequency using
the following convention:
Very common
≥ 1/10
Common
≥ 1/100 to ≥ 1/10
Uncommon
≥ 1/1,000 to < 1/100
Rare
≥ 1/10,000 to < 1/1,000
Very rare
<1/10,000
Within easy frequency grouping, undesirable effects are presented in
order of decreasing seriousness.
System Organ Class
Frequency
Skin and subcutaneous tissue
disorder
Unknown
Skin reactions
Skin irritation
Pruritis
Contact dermatitis
4.9 Overdose
Not relevant to topical use.
5. Pharmacological properties
5.1 Pharmacodynamic properties
Tolnaftate
Topical antifungal agent (ATC Classification: D01AE 18)
5.2 Pharmacokinetic properties